Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Erik Hjorth"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jakobsen, Jasna, Kareem, Ahsan
Publikováno v:
In Journal of Wind Engineering & Industrial Aerodynamics February 2023 233
Autor:
Ceren Emre, Luis E. Arroyo-García, Khanh V. Do, Bokkyoo Jun, Makiko Ohshima, Silvia Gómez Alcalde, Megan L. Cothern, Silvia Maioli, Per Nilsson, Erik Hjorth, André Fisahn, Nicolas G. Bazan, Marianne Schultzberg
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-15 (2022)
Intranasal administration of pro-resolving lipid mediators improves memory deficits and reduce microglial activation in a mouse model for Alzheimer’s disease, suggesting a future therapy.
Externí odkaz:
https://doaj.org/article/19b3984474bb4b898093a4daa1c00e69
Autor:
Ceren Emre, Khanh V. Do, Bokkyoo Jun, Erik Hjorth, Silvia Gómez Alcalde, Marie-Audrey I. Kautzmann, William C. Gordon, Per Nilsson, Nicolas G. Bazan, Marianne Schultzberg
Publikováno v:
Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-26 (2021)
Abstract Sustained brain chronic inflammation in Alzheimer’s disease (AD) includes glial cell activation, an increase in cytokines and chemokines, and lipid mediators (LMs), concomitant with decreased pro-homeostatic mediators. The inflammatory res
Externí odkaz:
https://doaj.org/article/ac96393851724d43b1cdd2767bc6342b
Autor:
Khanh V. Do, Erik Hjorth, Ying Wang, Bokkyoo Jun, Marie-Audrey I. Kautzmann, Makiko Ohshima, Maria Eriksdotter, Marianne Schultzberg, Nicolas G. Bazan
Publikováno v:
Cellular and Molecular Neurobiology. 43:797-811
Alzheimer’s disease (AD) develops into dementia over a period of several years, during which subjective cognitive impairment (SCI) and mild cognitive impairment (MCI) can be used as intermediary diagnoses of increasing severity. Chronic neuroinflam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10806f575868ceeb8f2c31d93276f057
https://doi.org/10.1007/s10571-022-01216-5
https://doi.org/10.1007/s10571-022-01216-5
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 11 (2018)
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by progressive memory loss and dementia. Accumulating evidence suggests that inflammation is involved in the pathogenesis of AD. Epidemiological studies suggest that use of anti-
Externí odkaz:
https://doaj.org/article/4be1a35b1fdd49bdb4ec4511401d3726
Autor:
Xiuzhe Wang, Erik Hjorth, Inger Vedin, Maria Eriksdotter, Yvonne Freund-Levi, Lars-Olof Wahlund, Tommy Cederholm, Jan Palmblad, Marianne Schultzberg
Publikováno v:
Journal of Lipid Research, Vol 56, Iss 3, Pp 674-681 (2015)
Specialized proresolving mediators (SPMs) induce resolution of inflammation. SPMs are derivatives of n-3 and n-6 PUFAs and may mediate their beneficial effects. It is unknown whether supplementation with PUFAs influences the production of SPMs. Alzhe
Externí odkaz:
https://doaj.org/article/85d04510a8f441548ff1400100c09aa1
Autor:
Maria Eriksdotter, Avin Tofiq, Tommy Cederholm, Henrik Zetterberg, Marianne Schultzberg, Hans Basun, Gerd Faxén-Irving, Yvonne Freund-Levi, Erik Hjorth, Fredrik Jernerén, Lars-Olof Wahlund, Jan Palmblad, Kaj Blennow
Publikováno v:
Journal of Alzheimer's Disease. 83:1291-1301
Background: Studies have suggested a connection between a decrease in the levels of polyunsaturated fatty acids (PUFAs) and Alzheimer’s disease (AD). We aimed to assess the effect of supplementation with omega-3 fatty acids (n-3 FAs) on biomarkers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73db003987fe4e5fec6270c120bd0108
https://doi.org/10.3233/jad-210007
https://doi.org/10.3233/jad-210007